Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1726-1729

  Bencsik, Zsuzsa ^b   Szabolcs, István ^a   Kovács, Zsuzsa ^a   Ferencz, Antal ^a   Vörös, Attila ^a   Kaszás, Ilona ^a   Bor, Katalin ^a   Gönczi, Judit ^a   Góth, Miklós ^a   Kovács, László ^a   Dohán, Orsolya ^a   Szilágyi, Géza ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Dist Hosp Szekesfehervar   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

ADOLESCENT; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CARCINOMATOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

ADENOMA; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RENIN;

EID: 9344253814     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.5.1726     Document Type: Article

References (30)

1. Copeland PM. 1983 The incidentally discovered adrenal mass. Ann Intern Med. 98:940-945.
2. Gross MD, Shapiro B, Bouffard JA, et al. 1988 Distinguishing benign from malignant euadrenal masses. Ann Intern Med. 109:613-618.
3. Glazer HS, Weymann PJ, Sagel SS, Levitt RG, McClennon BL. 1982 Non-functioning adrenal masses: incidental discovery on computed tomography. Am J Roentgenol. 139:81-85.
4. Kley H-K, Wagner H, Jaresch S, Jungbluth R, Schlaghecke R. 1990 Endokrin inaktive Nebennierentumoren. In: Allolio B, Schulte HM, eds. Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Stuttgart, New York: Schattauer; 189-197.
5. Delemer B, Gibold C, Caron J, Lien JC, Delisle MJ. 1992 Role of adrenocortical scintigraphy in the exploration of incidentally discovered rumours. Ann Endocrinol (Paris). 53:147-152.
6. Rufini V, Troncone L, Daidone MS, Corsello SM, Danza FM. 1994 Contribution of nuclear medicine to the diagnosis of silent adrenal masses. Radiol Med (Torino). 87:319-326.
7. Rosen HN, Swartz SL. 1992 Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am J Med. 92:213-216.
8. Rácz K, Pinet F, Marton T, Szende B, Gláz E, Corvol P. 1993 Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and "nonfunctioning" adrenal adenomas. J Clin Endocrinol Metab. 77:677-682.
9. Monta K, Sakakibara N, Seki T, Sasaki Y, Hisajima S, Itoh Y. 1994 Clinical study of 25 cases with adrenal tumor-comparison between transabdominal, translumbal, laparoscopic approach. Nippon Hinyokika Gakkai Zasshi. 85: 778-784.
10. Huiras CM, Pehling GB, Caplan RH. 1989 Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. JAMA. 261: 894-898.
11. Beyer HS, Doe RP. 1986 Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J Clin Endocrinol Metab. 62:1317-1321.
12. Virkkala A, Valimaki M, Pelkonen R, et al. 1989 Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinol (Copenh). 121:67-72.
13. Osella G, Terzolo M, Borretta G, et al. 1994 Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab. 79:1532-1539.
14. Flecchia D, Mazza E, Carlini M, et al. 1995 Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf). 42:129-134.
15. Chodosh LA, Daniels GH. 1993 Addison's disease. Endocrinologist. 3:166-181.
16. Galen RS, Gambino SR. 1975 Beyond normality: the predictive value and efficiency of medical diagnosis. New York: Wiley and Sons.
17. Barrett-Connor E, Khaw KT, Yen SSC. 1988 A prospective study of dehydroepiandrosterone sulphate, mortality and cardiovascular disease. N Engl J Med. 315:1519-1524.
18. Couch RM. 1992 Dissociation of Cortisol and adrenal androgen secretion in poorly controlled insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh). 126:115-117.
19. Ebeling P, Kiovisto VA. 1994 Physiological importance of dehydroepiandrosterone. Lancet. 343:1479-1491.
20. Lephart ED, Baxter CR, Parker Jr CR. 1987 Effect of burn trauma on adrenal, and testicular steroid hormone production. J Clin Endocrinol Metab. 64:842-848.
21. Semple CG, Gray CE, Beastall GH. 1987 Adrenal androgens and illness. Acta Endocrinol (Copenh). 116:155-160.
22. Wade CE, Lidberg JS, Cockrell JL, et al. 1988 Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab. 67:223-227.
23. Parker LN, Levin ER, Lifrak ET. 1985 Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 60:947-952.
24. Parker L, Odell W. 1980 Control of adrenal androgen secretion. Endocr Rev. 1:392-410.
25. Glazer GM, Woolsey EJ, Borrello J, et al. 1986 Adrenal tissue characterization using MR imaging. Radiology. 158:73-79.
26. Reining JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH. 1986 Adrenal masses differentiated by MR. Radiology. 158:81-84.
27. Chezmar JL, Robbins SM, Nelson RC, Steinberg HV, Torres WE, Bernardino ME. 1988 Adrenal masses characterization by T1-weighted MR imaging. Radiology. 166:357-359.
28. Gross MD, Sharpio B, Bouffard JA, et al. 1988 Distinquishing benign from malignant euadrenal masses. Ann Intern Med. 109:613-618.
29. Krestin GP, Steinbrich W, Friedman G. 1989 Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA enhanced dynamic studies. Radiology. 171:675-680.
30. Krestin GP, Friedman R, Fischbach R, Neufang KFR, Allolio B. 1991 Evaluation of adrenal masses in oncologic patients: dynamic contrast enhanced MR vs CT. J Comput Assist Tomogr. 15:104-110.